Catalent completes $5.5m expansion to help serve large-scale clinical studies

By Melissa Fassbender contact

- Last updated on GMT

(Image: Catalent Pharma Solutions)
(Image: Catalent Pharma Solutions)
The delivery technologies and development solutions provider Catalent Pharma Solutions today announced it has completed a $5.5m expansion program at its 200,000+ square foot Philadelphia, PA.

One of the largest sites in Catalent’s global clinical supply network, the expanded facility provides additional clinical packaging and storage capacity.

According to the company, the investment has resulted in a 40% increase in pallet space for both refrigerated and ambient clinical storage. It has also added extra cold chain packaging areas and a new clinical label control area. Additionally, the facility features a new environmental monitoring and building management system.

“Studies have become more global and complex, so the mix of services required to supply them has grown too,"​ said Bernie Clark, vice president of marketing and strategy for clinical supply services at Catalent.

Additionally, Clark said the company is experiencing strong growth from both long-term and new partners.

"As sponsors often don’t have all the resources themselves, they are reassessing their outsourcing strategy,"​ he told us.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Related suppliers

Follow us

Products

View more

Webinars